Only 6 more trading days until the results report. For those who might use momentum (up or down) to guide their trades during this period, I suggest you think about the following guidance updates provided by Acrow:
Date of Guidance
FY24 Revenue Guidance
% Revenue Increase over PCP
FY24 EBITDA Guidance
% EBITDA Increase over PCP
1
Aug-23
$190-200M
16%
$67-70M
29%
2
Nov-23
$215-225M
31%
$72-75M
38%
3
Mar-24
$215-225M
31%
$73-76M
40%
Given the positive trend in guidance updates, Acrow's excellent record of beating guidance over several years, and the acquisition of MI Scaffold in November 23 (which Acrow expected to contribute high single digit EPS accretion on pro-forma basis), I am very confident that the high end of guidance will be met.
It is inconceivable to me that Acrow is on a sub-10 P/E given ROE and EBITDA growth are both > 30%. It has achieved high growth rates for at least 4 years now. IMO a growth stock valued as if it had no growth.
ACF Price at posting:
$1.07 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)